πŸ‡ΊπŸ‡Έ FDA
Patent

US 7842706

Pharmaceutical composition

granted A61KA61K31/135A61K31/19

Quick answer

US patent 7842706 (Pharmaceutical composition) held by Takeda Pharmaceutical Company Limited expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/135, A61K31/19, A61K31/415, A61K31/42